Alnylam Pharmaceuticals
ALNY
#430
Rank
โ‚น4.929 T
Marketcap
โ‚น37,311
Share price
2.02%
Change (1 day)
73.01%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company